Analysts at UBS AG raised their price target on shares of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) from $23.00 to $30.00 in a research note to investors on Friday, January 17th. They now have a “buy” rating on the stock. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) stock opened at $26.10 in last session, and closed at $26.80, while the day range of AUXL stock is $26.19-27.35.The stock showed a positive weekly performance of 13.18%.
Columbia Laboratories Inc. (NASDAQ:CBRX) stock opened at $6.71, in last session and closed at $6.90, by gained 3.54%. The 52 week range of $4.49-8.37.Company’s market capitalization is $83.84 million.
ANI Pharmaceuticals (NASDAQ:ANIP) was downgraded by Zacks to a “neutral” rating in a research note issued on Friday, ARN reports. They currently have a $23.90 target price on the stock. Zacks price target would indicate a potential upside of 4.92% from the company’s current price. ANI Pharmaceuticals Inc (NASDAQ:ANIP) stock gained 1.42% and finished the last session at $21.47.The EPS of the stock remained -7.45.Company’s market capitalization is $205.04 million.
Endo Health Solutions (NASDAQ:ENDP) has been downgraded by The Street Ratings from buy to hold. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Endo Health Solutions Inc (NASDAQ:ENDP) stock opened the session at $71.89, and closed the session at $71.64.The 52 week range of the ENDP stock remained $27.70-72.66 and the day range was $71.19 – $72.25.